US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery: market research reports

RSS Feeds

Drug Discovery market research reports and industry analysis

6  7  8  9    11    13  14  15  
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... the Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD), complete with comparative analysis at various ...  |  read more...
$2,000.00
Epithelial Ovarian Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Epithelial Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Chronic Heart Failure - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Chronic Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Open-Angle Glaucoma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Open-Angle Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Myocardial Ischemia - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Myocardial Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Helicobacter Pylori Infections - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Helicobacter Pylori Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Nasopharyngeal Cancer - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Nasopharyngeal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Brain Metastasis - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Brain Metastasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
Pulmonary Hypertension - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Pulmonary Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Measles - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... Measles, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
$2,000.00
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Relapsed Chronic Lymphocytic Leukemia (CLL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
$2,000.00
Rotavirus Infections - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Rotavirus Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Peripheral T-Cell Lymphomas (PTCL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
Arteriosclerosis - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... Arteriosclerosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
$2,000.00
Liver Transplantation - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Liver Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Vulvovaginal Candidiasis - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Vulvovaginal Candidiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Gastrointestinal Stromal Tumor (GIST), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
$2,000.00
Brain Tumor - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Brain Tumor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Malignant Mesothelioma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Malignant Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Malignant Pleural Mesothelioma - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Malignant Pleural Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... Liver Disease (NAFLD)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of ...  |  read more...
$2,000.00
Kidney Fibrosis - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... therapeutic development for Kidney Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
$2,000.00
Angina (Angina Pectoris) - Pipeline Review, H1 2014
2/28/2014 | published by: Global Markets Direct
... information on the therapeutic development for Angina (Angina Pectoris), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
$2,000.00
6  7  8  9    11    13  14  15  
 
Our Clients